FDA panel debates lower-dose Moderna COVID booster

U.S. health advisers are debating if those who received Moderna COVID-19 vaccinations should get a booster at half the original dosage. But they stress the priority is still to get shots to the 66 million unvaccinated Americans who are eligible. (Oct. 14)

      

Read more here